A 79-year-old patient from Montergue who received the AstraZeneca vaccine last Saturday has had a cerebral venous thrombosis of the past few days.
Also read: AstraZeneca Vaccine: “I haven’t looked back and I’m fine,” says Dr. Richard Massey
Also read: COVID-19: Minister Christian Dube will be vaccinated on Thursday
Although it is too early to point the finger at the vaccine, the foundation has prepared a backlash report to send it to Health Canada. The patient was admitted to the Hôpital Honoré-Mercier Hospital, in Saint-Hyacinthe, where he was taken care of. Get away with impunity without significant implications.
Photo by AFP
A patient admitted to Honoré-Mercier Hospital in Saint-Hyacinthe received a dose of AstraZeneca vaccine similar to this one.
This is the first reported case of blood clots after the vaccine was administered in Canada. Cerebral thrombosis is a blockage of a blood clot in the venous system that leads blood to the brain.
Several European countries, including France and Germany, have discontinued doses of the AstraZeneca vaccine after suspected cases of thrombosis.
In Spain, health authorities are investigating three cases of people who developed blood clots after receiving the vaccine, including a 43-year-old professor who died of a brain haemorrhage.
WHO recommended
Despite everything, the World Health Organization recommended yesterday, to continue vaccination, despite the controversy, considering that the benefits are greater than the risks.
The Canadian governments and Quebec also decided to continue mass vaccination.
On Tuesday, the National Advisory Committee on Immunization also decided to expand its recommendations to include the AstraZeneca vaccine for people 65 and older. However, vaccination is being closely monitored across the country.
According to data compiled by Health Canada, there were fewer than 2,000 cases of side effects in more than 2.2 million vaccinated people in the country.
Few serious reactions
The majority of it is redness or pain near the injection site.
Only 214 serious side effects were reported, Especially allergies.
These numbers, dating back to March 5, only relate to Pfizer / BioNtech and Moderna vaccines. The Astra-Zeneca vaccine was only approved on February 26 and has only been distributed in Quebec for a little over a week.
In an interview with 98.5 FM, Dr.s Carl Weiss said yesterday morning that it is still necessary to continue vaccination, especially in 60 years and over.
According to the head of the infectious diseases department at the Jewish General Hospital, the risk of developing a blood clot from COVID-19 is greater than the vaccine produced by AstraZeneca.
He believes the Quebec government should properly document vaccination with reliable data to reassure the population. Although the safety of the AstraZeneca vaccine has not been questioned, questions have been raised in Europe.
A cloud on the head
Compared to two RNA vaccines from Pfizer and Moderna, which have been administered in several hundreds of millions of doses [jusqu’à] Currently, [ils] You don’t, if you will, have this cloud over the head in relation to the clot, “he points out. Health Canada indicated that yesterday it was impossible for them to answer our questions about the AstraZeneca vaccine.
“It will take our experts time to look for the most recent data,” said Anna Madison, a media relations consultant, adding that reports of negative reactions are being sent by regional public health authorities.
– With Agence France-Presse
“Evil thinker. Music scholar. Hipster-friendly communicator. Bacon geek. Amateur internet enthusiast. Introvert.”